(QUBT) Quantum Computing - Overview
Sector: Technology | Industry: Computer Hardware | Exchange: NASDAQ (USA) | Market Cap: 2.646m USD | Total Return: -17.9% in 12m
Industry Rotation: -13.5
Avg Turnover: 145M
EPS Trend: 21.9%
Qual. Beats: 0
Rev. Trend: 59.4%
Qual. Beats: 1
Warnings
Share dilution 46.4% YoY
High Debt/EBITDA (18.7) with thin interest coverage (-123.5)
High Debt while negative Cash Flow
Interest Coverage Ratio -123.5 is critical
Beneish M-Score 1.00 > -1.5 - likely earnings manipulation
Altman Z'' -6.87 < 1.0 - financial distress zone
Tailwinds
No distinct edge detected
Quantum Computing Inc. (QUBT) is an integrated photonics company that develops hardware for commercial and government sectors. Its core technology focuses on thin-film lithium niobate (TFLN) chips, which are essential for high-performance optical devices including electro-optical modulators and frequency conversion tools. TFLN is increasingly prioritized in the industry due to its high bandwidth and low power consumption compared to traditional silicon photonics.
The company’s product pipeline includes the Entropy Quantum Computer (EQC) for optimization problems and various reservoir computing machines, such as Emucore and Neurawave, designed for neural network applications. Beyond computing, QUBT produces specialized hardware like LiDAR for low-visibility environments and photonic vibrometers for remote sensing. Most companies in the quantum sector operate on long-term R&D cycles, often relying on government contracts or strategic partnerships to fund the transition from prototype to commercial scale.
For a deeper analysis of the companys fundamentals and valuation, consider reviewing the detailed reports on ValueRay. Based in Hoboken, New Jersey, the firm underwent a significant pivot in its business model, having originally been founded in 2001 as Innovative Beverage Group Holdings, Inc.
- Commercial adoption of Thin-Film Lithium Niobate chips drives hardware revenue growth
- Success of Entropy Quantum Computer in solving optimization problems impacts valuation
- Government contract awards for LiDAR and vibrometer technologies dictate cash flow
- High research and development expenditures necessitate frequent capital raises and dilution
- Scalability of photonic reservoir computing determines competitive positioning against traditional AI hardware
| Net Income: -39.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.03 > 0.02 and ΔFCF/TA 6.88 > 1.0 |
| NWC/Revenue: 22.8k% < 20% (prev 42.5k%; Δ -19.6k% < -1%) |
| CFO/TA -0.02 > 3% & CFO -35.3m > Net Income -39.7m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 66.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (224.0m) vs 12m ago 46.39% < -2% |
| Gross Margin: -15.39% > 18% (prev -7.71%; Δ -768.1% > 0.5%) |
| Asset Turnover: 0.47% > 50% (prev 0.16%; Δ 0.31% > 0%) |
| Interest Coverage Ratio: -123.5 > 6 (EBITDA TTM -52.5m / Interest Expense TTM 288k) |
| A: 0.61 (Total Current Assets 1.01b - Total Current Liabilities 15.1m) / Total Assets 1.62b |
| B: -0.14 (Retained Earnings -223.2m / Total Assets 1.62b) |
| C: -0.04 (EBIT TTM -35.6m / Avg Total Assets 931.5m) |
| D: -9.68 (Book Value of Equity -226.1m / Total Liabilities 23.4m) |
| Altman-Z'' Score: -6.87 = D |
| DSRI: 62.82 (Receivables 14.1m/20.0k, Revenue 4.33m/385k) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 1.39 (AQ_t 0.37 / AQ_t-1 0.26) |
| SGI: 11.26 (Revenue 4.33m / 385k) |
| TATA: -0.00 (NI -39.7m - CFO -35.3m) / TA 1.62b) |
| Beneish M-Score: 55.44 (Cap -4..+1) = D |
Over the past week, the price has changed by -4.57%, over one month by -1.17%, over three months by +18.33% and over the past year by -17.88%.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 17.8 | 83.4% |
P/B = 1.3546
Revenue TTM = 4.33m USD
EBIT TTM = -35.6m USD
EBITDA TTM = -52.5m USD
Long Term Debt = 1.81m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = unknown (none)
Debt = 3.68m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -982.4m USD (recalculated: Debt 3.68m - CCE 986.1m)
Enterprise Value = 1.66b USD (2.65b + Debt 3.68m - CCE 986.1m)
Interest Coverage Ratio = -123.5 (Ebit TTM -35.6m / Interest Expense TTM 288k)
EV/FCF = -39.54x (Enterprise Value 1.66b / FCF TTM -42.1m)
FCF Yield = -2.53% (FCF TTM -42.1m / Enterprise Value 1.66b)
FCF Margin = -970.6% (FCF TTM -42.1m / Revenue TTM 4.33m)
Net Margin = -916.2% (Net Income TTM -39.7m / Revenue TTM 4.33m)
Gross Margin = -15.39% ((Revenue TTM 4.33m - Cost of Revenue TTM 5.00m) / Revenue TTM)
Gross Margin QoQ = -19.53% (prev -49.49%)
Tobins Q-Ratio = 1.03 (Enterprise Value 1.66b / Total Assets 1.62b)
Interest Expense / Debt = 4.65% (Interest Expense 171k / Debt 3.68m)
Taxrate = 21.0% (US default 21%)
NOPAT = -28.1m (EBIT -35.6m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 66.67 (Total Current Assets 1.01b / Total Current Liabilities 15.1m)
Debt / Equity = 0.00 (Debt 3.68m / totalStockholderEquity, last quarter 1.60b)
Debt / EBITDA = 18.71 (negative EBITDA) (Net Debt -982.4m / EBITDA -52.5m)
Debt / FCF = 23.36 (negative FCF - burning cash) (Net Debt -982.4m / FCF TTM -42.1m)
Total Stockholder Equity = 1.12b (last 4 quarters mean from totalStockholderEquity)
RoA = -4.26% (Net Income -39.7m / Total Assets 1.62b)
RoE = -3.55% (Net Income TTM -39.7m / Total Stockholder Equity 1.12b)
RoCE = -3.18% (EBIT -35.6m / Capital Employed (Equity 1.12b + L.T.Debt 1.81m))
RoIC = -2.93% (negative operating profit) (NOPAT -28.1m / Invested Capital 957.4m)
WACC = 3.19% (E(2.65b)/V(2.65b) * Re(3.19%) + D(3.68m)/V(2.65b) * Rd(4.65%) * (1-Tc(0.21)))
Discount Rate = 3.19% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares (quarterly) Correlation: 82.22 | Cagr: 60.31%
[DCF] Fair Price = unknown (Cash Flow -42.1m)
EPS Correlation: 21.89 | EPS CAGR: 10.26% | SUE: 0.02 | # QB: 0
Revenue Correlation: 59.39 | Revenue CAGR: 193.0% | SUE: 2.81 | # QB: 1
EPS current Quarter (2026-06-30): EPS=-0.08 | Chg30d=-23.08% | Revisions=-20% | Analysts=1
EPS next Quarter (2026-09-30): EPS=-0.08 | Chg30d=-14.29% | Revisions=N/A | Analysts=1
EPS current Year (2026-12-31): EPS=-0.33 | Chg30d=-29.41% | Revisions=N/A | GrowthEPS=-1.8% | GrowthRev=+3108.0%
EPS next Year (2027-12-31): EPS=-0.28 | Chg30d=+5.00% | Revisions=N/A | GrowthEPS=+13.6% | GrowthRev=+50.6%
[Analyst] Revisions Ratio: -20%